Poland· PL-100482880

Lurasidone Teva

A lurasidone product containing lurasidoni hydrochloridum, registered in Poland by Teva B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC N05AE05

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lurasidoni hydrochloridumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lurasidone is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AE05 (lurasidone), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search lurasidone products by name

Lurasidone · ATC N05AE05

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lurasidone costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $2.63 in Italy to $6.45 in Switzerland — a ×2.4 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lurasidone · price per daily dose (60 mg)

USD · FX 28 Sept 2026

CH Switzerland$6.45
IT Italy$2.63

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Lurasidoni hydrochloridum
Manufacturer: Teva B.V.
Country: Poland (PL)
ATC code: N05AE05
ATC class: Lurasidone
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 1

1 priced

gtin
05909991560775
28 szt.
PLN 55.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

242 interactions on record for lurasidone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lurasidone against other medicines How interaction checks work

Lurasidone · interactions on record

242 records

32 severe
205 moderate

Most severe, free to view

MetoclopramideA03FA01severe
AprepitantA04AD12severe
KetoconazoleH02CA03severe
ErythromycinJ01FA01severe

5 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lurasidone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lurasidone products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

Austria · Lurasidon G.L., Lurasidon Genericon
Bulgaria · Lurasidone Accord, Луразидон Тева
Czechia · Isaq, Lurasidon G.L. Pharma
Germany · Lurasidon Elpen
Denmark · Elgera, Lurasidone Accord
Spain · Lurasidona Cinfa, Lurasidona Tecnigen
Finland · Lurasidone Accord
United Kingdom (Northern Ireland) · Lurasidone Accord Healthcare, Lurasidone Amarox
Greece · Elgera, Latomno
Croatia · Lurasidon Teva
Iceland · Latuda
Italy · Lurasidone Accord, Lurasidone Doc
Liechtenstein · Latuda
Netherlands · Lurasidon Teva
Norway · Latuda, Lurasidone Accord
Portugal · Latomno, Lurasidona Farmoz
Sweden · Lurasidon G.L. Pharma, Lurasidone Accord
Slovenia · Lurasidon Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/eea3b237-fe6f-47fb-adea-1950e5be5139
GET /v1/drugs/eea3b237-fe6f-47fb-adea-1950e5be5139?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "37 mg",
  "packaging": "05909991560775 ¦ Rp ¦ 159376\n28 tabl.",
  "substance": "Lurasidoni hydrochloridum 37.24 mg",
  "common_name": "Lurasidoni hydrochloridum",
  "pl_product_id": "100482880",
  "pozwolenie_nr": "28760",
  "auth_procedure": "DCP",
  "authorisation_validity": "2029-12-13"
}

API reference MCP server Plans

See everything about lurasidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console